Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

A landmark clinical trial from St Bartholomew’s Hospital reveals that the Apple Watch detects recurring AFib faster and ...

Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...

CathVision today announced significant clinical and scientific progress in Pulsed Field Ablation (PFA) with its PFAnalyzertm ...

Cardiology has been shifting to the outpatient setting for years — a transition recently accelerated by technology and payer incentive alignment toward ASCs. In its 2026 final rule published Nov. 21, ...

Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave ...

The cardiac mapping devices market offers opportunities driven by rising cardiovascular diseases, an aging population, and a ...

First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of ...

Kardium has unveiled further results from the pivotal trial of its Globe Pulsed Field System, demonstrating the system’s success in pulmonary vein isolation (PVI) and paroxysmal atrial fibrillation ...

Abbott Park, Illinois Thursday, January 22, 2026, 09:00 Hrs [IST] ...